N-Desmethylclozapine: Is There Evidence for its Antipsychotic Potential?
@article{Mendoza2009NDesmethylclozapineIT, title={N-Desmethylclozapine: Is There Evidence for its Antipsychotic Potential?}, author={Maria Cristina Mendoza and Jean-Pierre Lindenmayer}, journal={Clinical Neuropharmacology}, year={2009}, volume={32}, pages={154-157} }
Objective:N-Desmethylclozapine (NDMC), one of clozapine's major metabolites, has become a recent focus of study for both its antipsychotic and metabolic effects. The aim of this review is to examine NDMC's biological activity in the context of the pathophysiology of schizophrenia and to critically evaluate the few recent preclinical and clinical studies of NDMC's potential antipsychotic effects to predict its therapeutic potential. Results:We review the complex interaction between clozapine and…
40 Citations
The clozapine metabolite N-desmethylclozapine displays variable activity in diverse functional assays at human dopamine D₂ and serotonin 5-HT₁A receptors.
- Biology, PsychologyEuropean journal of pharmacology
- 2011
Effects of clozapine and N-desmethylclozapine on synaptic transmission at hippocampal inhibitory and excitatory synapses
- Psychology, BiologyBrain Research
- 2011
Plasma ratio of clozapine to N-desmethylclozapine can predict cognitive performance in treatment-resistant psychotic patients
- Psychology, MedicinePsychiatry Research
- 2017
The relationship between plasma levels of clozapine and N-desmethyclozapine as well as M1 receptor polymorphism with cognitive functioning and associated cortical activity in schizophrenia
- Psychology, MedicinePsychiatry Research: Neuroimaging
- 2020
Contributions of cholinergic receptor muscarinic 1 and CYP1A2 gene variants on the effects of plasma ratio of clozapine/N-desmethylclozapine on working memory in schizophrenia
- Psychology, MedicineJournal of psychopharmacology
- 2020
The finding that the relationship between clozapine/N-desmethylclozAPine and working memory is specific to patients with potentially higher transcription of M1 receptor (i.e. non-carriers of the haplotype T-A of cholinergic receptor muscarinic 1) supports a cholinerential mechanism underlying this relationship.
Rationale and neurobiological effects of treatment with antipsychotics in patients with chronic schizophrenia considering dopamine supersensitivity
- Psychology, MedicineBehavioural Brain Research
- 2021
Muscarinic mechanisms in psychotic disorders.
- Psychology, MedicineHandbook of experimental pharmacology
- 2012
It is proposed that an agonist with M(1) and M(4) interactions would effectively treat core symptom clusters associated with schizophrenia.
Interest of Fluvoxamine as an Add-On to Clozapine in Children With Severe Psychiatric Disorder According to CYP Polymorphisms: Experience From a Case Series
- Psychology, MedicineFrontiers in Psychiatry
- 2021
Four pediatric cases with severe psychiatric disorders underlying the experience with CYP polymorphism explorations and the use of fluvoxamine as add-on to clozapine are reported and a detailed step-by-step multidisciplinary protocol is proposed.
Effects of adjunctive fluvoxamine on metabolic parameters and psychopathology in clozapine-treated patients with schizophrenia: A 12-week, randomized, double-blind, placebo-controlled study
- Psychology, MedicineSchizophrenia Research
- 2018
Association of clozapine-related metabolic disturbances with CYP3A4 expression in patients with schizophrenia
- Psychology, MedicineScientific reports
- 2020
CYP3A4-status can identify patients with increased risk for metabolic side-effects and prevent their development by careful therapeutic strategy, and norclozapine/clozAPine ratio correlated with fasting glucose levels, triglyceride concentrations and BMI.
References
SHOWING 1-10 OF 25 REFERENCES
Evaluation of N-Desmethylclozapine as a Potential Antipsychotic—Preclinical Studies
- Psychology, MedicineNeuropsychopharmacology
- 2007
NDMC was not very effective in reducing AIL or CAR and showed minimal induction of Fos in the nucleus accumbens, however, its freedom from catalepsy and prolactin elevation, and its unique pharmacological profile may make it feasible to use this drug as an adjunctive treatment to existing antipsychotic regimens.
N-Desmethylclozapine, a Major Metabolite of Clozapine, Increases Cortical Acetylcholine and Dopamine Release In Vivo Via Stimulation of M1 Muscarinic Receptors
- Psychology, BiologyNeuropsychopharmacology
- 2005
NDMC, because of its M1 agonism, may more effectively treat the cognitive impairments observed in schizophrenia than clozapine itself; and M1 receptor agonism may be a valuable target for the development of drugs that can improve cognitive deficit in schizophrenia, and perhaps other neuropsychiatric disorders as well.
Clozapine and N-desmethylclozapine are potent 5-HT1C receptor antagonists.
- Psychology, ChemistryEuropean journal of pharmacology
- 1993
The role of 5-HT2C receptor polymorphisms in the pharmacogenetics of antipsychotic drug treatment
- Psychology, MedicineProgress in Neuro-Psychopharmacology and Biological Psychiatry
- 2005
N-Desmethylclozapine, a Major Clozapine Metabolite, Acts as a Selective and Efficacious δ-Opioid Agonist at Recombinant and Native Receptors
- Biology, PsychologyNeuropsychopharmacology
- 2007
It is demonstrated for the first time that NDMC acts as a selective and efficacious δ-opioid receptor agonist and suggested that this unique property may contribute, at least in part, to the clinical actions of the atypical antipsychotic clozapine.
Pharmacokinetics and Pharmacodynamics of Clozapine
- Psychology, MedicineClinical pharmacokinetics
- 1993
Careful patient selection and monitoring are required when clozapine therapy is used in patients with schizophrenia because the drug does possess significant binding affinity for different dopamine receptors, with recent evidence supporting binding to the D4 receptor subtype.
N‐desmethylclozapine: a clozapine metabolite that suppresses haemopoiesis
- Medicine, PsychologyBritish journal of haematology
- 1994
It is suggested that N‐desmethylclozapine, the major metabolite of clozAPine, is itself toxic or is further metabolized to an unstable compound which is toxic to haemopoietic precursors of both myeloid and erythroid lineages.
Intrinsic Efficacy of Antipsychotics at Human D2, D3, and D4 Dopamine Receptors: Identification of the Clozapine Metabolite N-Desmethylclozapine as a D2/D3 Partial Agonist
- Psychology, MedicineJournal of Pharmacology and Experimental Therapeutics
- 2005
Using a cell-based functional assay, it is demonstrated that overexpression of Gαo induces constitutive activity in the human D2-like receptors (D2, D3, and D4) and it is proposed that bypassing clozapine blockade through direct administration of NDMC to patients may provide superior antipsychotic efficacy.
The highly efficacious actions of N-desmethylclozapine at muscarinic receptors are unique and not a common property of either typical or atypical antipsychotic drugs: is M1 agonism a pre-requisite for mimicking clozapine’s actions?
- Psychology, MedicinePsychopharmacology
- 2004
Results are consistent with the notion that a balanced degree of activity at multiple biogenic amine receptors, including M1 muscarinic agonism, is responsible for the uniquely beneficial actions of clozapine.